No abstract available
MeSH terms
-
Administration, Oral
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology
-
Antineoplastic Agents / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Carcinoma, Non-Small-Cell Lung / epidemiology
-
Clinical Trials, Phase III as Topic
-
Docetaxel
-
Drug Administration Schedule
-
Drug Delivery Systems / methods
-
Drug Delivery Systems / trends*
-
Drug Design
-
Drug Screening Assays, Antitumor / methods
-
ErbB Receptors / classification
-
ErbB Receptors / drug effects
-
ErbB Receptors / metabolism
-
Erlotinib Hydrochloride
-
Expert Testimony
-
Humans
-
Quinazolines / chemistry
-
Quinazolines / pharmacology
-
Quinazolines / therapeutic use*
-
Randomized Controlled Trials as Topic
-
Taxoids / therapeutic use
-
Time Factors
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Quinazolines
-
Taxoids
-
Docetaxel
-
Erlotinib Hydrochloride
-
ErbB Receptors